RxDoctor Payments Data

Minesh Mehta, MD

Gastroenterology · Athens, GANPI 1295091494

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Boston Scientific at 45.9% of the total. Reporting peaked in 2023 at $14,745 and has fallen 75.9% since, to $3,560 in 2025. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,220in general payments, 2019–2025

Across 465 payments — averaging $69.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$15K
  • Wilson Cook Medical Incorporated$7K
  • Cook Medical LLC$3K
  • AbbVie$1K
  • Apollo Endosurgery US Inc$1K
  • Olympus America Inc.$789
  • plus $4K from 39 others

What the payments were for

  • Consulting fees$10,20032%
  • Speaking & faculty fees$7,49523%
  • Travel & lodging$3,98012%
  • Food & beverage$10,54533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,220 in reported general payments places this provider in the 90th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$140,978
Medicare patients
490
Services billed
1,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase57$143,624
LinzessLinaclotide23$14,936
ClenpiqSod Picosulf/Mag Ox/Citric Ac71$12,041
Pantoprazole Sodium341$3,849
Ondansetron OdtOndansetron44$1,364
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates12$693
Omeprazole58$545
Carvedilol17$342
Sucralfate13$298
Escitalopram Oxalate13$273
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl17$212
Allopurinol12$175
Metronidazole12$142
Famotidine18$126
Dicyclomine Hcl15$63

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,319$158,56080 claims
Ferring Pharmaceuticals Inc.Clenpiq$113$12,04171 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 492 gastroenterology providers in Georgia.

Other gastroenterology in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →